Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease

Distance Training Glossary | Print Version | Email This Page To A Friend

Training Details

Event Dates and Timeframe
Any Time
Location and Delivery Method
Delivery Method
Online / Web Delivered
Cost Range
This training is available from November 10, 2020 until November 10, 2021. Please see registration link below.

Host And Instructor

Psychiatry & Behavioral Health Learning Network
Marc E. Agronin, MD & Richard S. Isaacson, MD
class/provider logo image

Training Overview Description

Provided by North American Center for Continuing Medical Education, LLC (NACCME), an HMP Company.

This activity is designed for general and specialty neurologists, psychiatrists, neurology and psychiatric NPs, advanced practice nurses (APRNs), PAs, nurses, and other healthcare practitioners who care for patients with early AD.

For questions regarding this educational activity, please call 609-371-1137 or email

Event-specific Details

After participating in this activity, learners should be better able to:

  • Outline pharmacotherapeutic approaches for the treatment of cognitive and neuropsychiatric symptoms in early AD
  • Explain the clinical need for improved medications for the treatment of early AD

To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.

NACCME would like to thank the following company who has supported "Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease" through educational grants and/or in-kind support: Biogen


In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Estimated Time to Complete: 0.25 hour

NACCME designates this internet enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing nursing education activity awards 0.25 contact hour.

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.